Nicholas Investment Partners, LP Axsome Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

A detailed history of Nicholas Investment Partners, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 10,135 shares of AXSM stock, worth $909,514. This represents 0.1% of its overall portfolio holdings.

Number of Shares

10,135

Holding current value

$909,514

% of portfolio

0.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$78.93 - $95.84 $799,955 - $971,338	10,135 New	10,135 $910,000
Q1 2024 May 13, 2024	SELL	$69.39 - $97.64 $3.18 Million - $4.47 Million	-45,829 Reduced 55.45%	36,816 $2.94 Million
Q4 2023 Feb 07, 2024	SELL	$57.42 - $83.61 $17.9 Million - $26.1 Million	-312,335 Reduced 79.08%	82,645 $6.58 Million
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $6,648 - $7,892	96 Added 0.02%	394,980 $27.6 Million
Q2 2023 Aug 09, 2023	BUY	$58.41 - $90.35 $3.18 Million - $4.92 Million	54,454 Added 16.0%	394,884 $28.4 Million
Q1 2023 May 11, 2023	BUY	$58.39 - $75.0 $8.18 Million - $10.5 Million	140,176 Added 70.0%	340,430 $21 Million
Q4 2022 Feb 10, 2023	BUY	$39.94 - $79.72 $8 Million - $16 Million	200,254 New	200,254 $15.4 Million
Q2 2021 Aug 10, 2021	SELL	$50.63 - $73.5 $7.02 Million - $10.2 Million	-138,571 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $3.85 Million - $5.61 Million	-68,881 Reduced 33.2%	138,571 $7.85 Million
Q4 2020 Feb 11, 2021	BUY	$66.31 - $86.52 $1.31 Million - $1.7 Million	19,696 Added 10.49%	207,452 $16.9 Million
Q3 2020 Nov 13, 2020	BUY	$68.34 - $85.84 $11.3 Million - $14.2 Million	165,355 Added 738.16%	187,756 $13.4 Million
Q2 2020 Aug 12, 2020	SELL	$49.87 - $98.69 $1.72 Million - $3.39 Million	-34,400 Reduced 60.56%	22,401 $1.84 Million
Q1 2020 May 13, 2020	BUY	$41.2 - $101.31 $1.83 Million - $4.49 Million	44,358 Added 356.49%	56,801 $3.34 Million
Q4 2019 Feb 13, 2020	BUY	$16.71 - $106.24 $207,922 - $1.32 Million	12,443 New	12,443 $1.29 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.85B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account

Nicholas Investment Partners, LP Axsome Therapeutics, Inc. Transaction History